Laura L. Hagerty, Ph.D. - Publications
Affiliations: | 2007 | Duke University, Durham, NC |
Area:
PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Carlson DA, Franke AS, Weitzel DH, Speer BL, Hughes PF, Hagerty L, Fortner CN, Veal JM, Barta TE, Zieba BJ, Somlyo AV, Sutherland C, Deng JT, Walsh MP, MacDonald JA, et al. Fluorescence linked enzyme chemoproteomic strategy for discovery of a potent and selective DAPK1 and ZIPK inhibitor. Acs Chemical Biology. 8: 2715-23. PMID 24070067 DOI: 10.1021/Cb400407C | 0.439 | |||
2012 | Stimpson SA, Turner SM, Clifton LG, Poole JC, Mohammed HA, Shearer TW, Waitt GM, Hagerty LL, Remlinger KS, Hellerstein MK, Evans WJ. Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats. Journal of Applied Physiology (Bethesda, Md. : 1985). 112: 1940-8. PMID 22422801 DOI: 10.1152/Japplphysiol.00122.2012 | 0.393 | |||
2007 | Hagerty L, Weitzel DH, Chambers J, Fortner CN, Brush MH, Loiselle D, Hosoya H, Haystead TA. ROCK1 phosphorylates and activates zipper-interacting protein kinase. The Journal of Biological Chemistry. 282: 4884-93. PMID 17158456 DOI: 10.1074/Jbc.M609990200 | 0.577 | |||
2006 | Hagerty L, Haystead TA. Delineating signal transduction pathways in smooth muscle through focused proteomics. Expert Review of Proteomics. 3: 75-85. PMID 16445352 DOI: 10.1586/14789450.3.1.75 | 0.557 | |||
Show low-probability matches. |